Treatment Agreement
COMPREHENSIVE TREATMENT AGREEMENT
WITH MEDICINAL CANNABIS
CURA VIDA CLINICS
Responsible Entity: CURA VIDA CLINICS COSTA RICA LLC LIMITED LIABILITY COMPANY , company holding the legal entity identification number: 3-102-877646 , duly registered in the Registry of Legal Entities of Costa Rica, in volume 2023 , entry 333699 , company that is dedicated to the provision of health services exclusively as a medical consultation and wellness center through legal access to medicinal cannabis, hereinafter referred to as “ CURA VIDA CLINICS or CVCC ”.
Patient : You, the undersigned, hereby sign this Comprehensive Medical Cannabis Treatment Agreement. The patient is defined as any individual receiving comprehensive care (preventive, curative, or rehabilitative) at a public or private healthcare facility. You are recognized as a subject of rights, the protagonist of your own health, and capable of providing informed consent.
Legal Basis. This Agreement shall be governed by Costa Rican law, in particular by the following regulations : General Health Law No. 5395, Law No. 10113 Law of cannabis for medicinal and therapeutic use and of hemp for food and industrial use, its Technical Regulation RTCR 515:2024 Cannabis, Law No. 8968 Law of Protection of the Person against the Processing of his Personal Data, Law No. 8454 The Law of Certificates, Digital Signatures and Electronic Documents.
1) CLINICAL RELATIONSHIP AND AUTHORIZED PHYSICIANS.
This document regulates the therapeutic relationship between the patient and CURA VIDA CLINICS , as well as with the duly authorized medical professionals who provide services at CVCC .
CVCC operates under a rotating care model, so the attending physician may vary depending on availability, specialty, or internal organization.
Each medical procedure will be performed by a professional duly registered with the College of Physicians and Surgeons of Costa Rica, who will assume the corresponding professional responsibility.
CVCC -authorized physicians have full access to your internal medical record. This ensures consistent diagnosis and dosage throughout your treatment.
This Agreement remains in effect regardless of the CVCC doctor who issues your prescription at each appointment.
2) NATURE OF THE TREATMENT.
The patient acknowledges that treatment with medicinal cannabis may constitute a complementary or alternative therapy. Scientific evidence regarding its effectiveness may vary depending on the medical condition being treated, and a cure is not guaranteed.
The patient acknowledges that:
a) Medicinal cannabis can be a complementary or alternative therapy.
b) Scientific evidence may be limited for certain conditions.
c) No cure or specific results are guaranteed.
d) The treatment will be individualized and subject to ongoing medical evaluation.
3) INFORMED CONSENT.
I declare that I have received clear, sufficient and understandable information about:
a) The nature of treatment with medicinal cannabis.
b) Your expected benefits.
c) The possible risks and adverse effects.
d) The available therapeutic alternatives.
e) The option of not receiving treatment.
I understand that results may vary between patients and that there is no guarantee of therapeutic success, and that treatment may be discontinued if it is ineffective or harmful.
4) PRESCRIPTION AND DISPENSING.
CVCC operates exclusively as a medical service provider, not as a retailer or dispensary. In strict compliance with Law No. 10113, CVCC does not sell, distribute, market, or supply physical cannabis products.
In addition, it is important that you know the following:
a) Neither CVCC nor its doctors sell medications directly to patients.
b) Law No. 10113 prohibits growers and manufacturers from selling directly to patients.
c) Furthermore, the only legal point of sale for cannabis products is a pharmacy authorized by the Ministry of Health.
d) The patient has the right to freely choose the pharmacy where they will fill their prescription.
5) DIGITAL PRESCRIPTION SYSTEM.
Prescriptions containing cannabis will be issued through the official digital prescription system in accordance with current regulations. The patient authorizes the registration of their personal and clinical data in this system, including: full name, identification document, medical diagnosis, and treatment details. This data will be used exclusively to comply with regulatory obligations.
6) TELEMEDICINE.
The patient acknowledges that medical care may be provided via telemedicine, which may involve limitations in clinical evaluation due to the absence of an in-person physical examination.
The patient must sign a Telemedicine Care Consent form, which details the obligations of the parties, the associated risks, and the patient's rights.
7) PERSONAL DATA PROTECTION.
The data controller is CURA VIDA CLINICS ( CVCC ). Personal data will be used for:
a) Provide medical care
b) Manage the medical record
c) Comply with legal and regulatory obligations
The patient may exercise their rights of access, rectification, cancellation and opposition by sending a request to the email address provided by the clinic for this purpose.
The data will be processed in accordance with Law No. 8968 and will not be transferred to third parties without authorization, except where legally required.
8) CLINICAL RECORD.
The medical record will be safeguarded by CURA VIDA CLINICS under strict confidentiality and security measures, in accordance with current regulations and industry best practices.
9) RISKS AND ADVERSE EFFECTS.
The patient acknowledges that the use of medicinal cannabis may cause side effects, including, but not limited to:
a) Sleepiness
b) Dizziness
c) Cognitive impairments
d) Anxiety
e) Tachycardia
The patient agrees to report any adverse effects and to disclose all medications they are using.
10) DRIVING AND SAFETY.
The patient agrees not to drive or operate machinery under the influence of cannabis when there is impairment of their abilities, in accordance with current regulations.
11) PATIENT RESPONSIBILITIES.
The patient agrees to:
a) Use this medication for personal use only.
b) Do not share or distribute the product
c) Follow medical instructions
d) Keep the medication in safe conditions
Failure to comply with these obligations may affect the results of the treatment.
12) TERMINATION OF THE AGREEMENT.
CURA VIDA CLINICS may terminate this agreement in the event of:
a) Misuse of the medication
b) Failure to follow medical instructions
c) Conduct that affects the safety of personnel or third parties